LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTCPink:VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with $514,007 in revenue, compared to only $11,468 the previous year. This is an increase of $502,539, or 4382%. Gross profits for the same period grew from just $10,831 in 2020 to $511,335 in 2021, representing an increase of 4621%. Total assets in 2021 more than doubled over the previous year, growing from $120,476 in 2021 to $275,021, for an increase of 123%. The Company also reduced its total liabilities more than 25% from $3,631,096 in 2020 to $2,710,201 in 2021.
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
